Research Team & Achievements
World-Class Scientific Talent Driving Biopharmaceutical Innovation
Huayu Biopharma boasts a world-class R&D team composed of returned PhDs, senior industry experts, and young scientific talents. Our team members have profound academic expertise and extensive industrialization experience in cell therapy, recombinant proteins, and antibody drugs.
The company has established a provincial-level enterprise technology center and a postdoctoral research station, maintaining close industry-academia collaborations with renowned universities and research institutions worldwide. We have secured over 50 granted patents, published 100+ SCI papers, and undertaken 10+ national-level research projects.
Research Groups
Multidisciplinary teams of scientific excellence
Cell Therapy Research Group
Focusing on Tumor Immunotherapy & Cell Engineering
Led by 5 PhDs with a team of 15 researchers, dedicated to developing cutting-edge cell therapies including CAR-T and TCR-T technologies. The group has established a comprehensive cell engineering platform with 3 core patents, and related products have entered preclinical studies.
Protein Engineering Research Group
Genetic Recombination & Protein Expression Optimization
Led by 4 PhDs with a team of 12 researchers, focusing on expression system development and process optimization for recombinant protein drugs. The team's proprietary high-efficiency expression platform has achieved industrialization of multiple protein products, with 8 patent applications filed.
Antibody Drug Research Group
Monoclonal, Bispecific & ADC Drug Development
Led by 6 PhDs with a team of 18 researchers, covering the full chain from antibody discovery to engineering and druggability assessment. The team holds leading advantages in bispecific antibodies and ADCs, with 2 candidate drugs entering IND filing stage.
Key Achievements
Innovation-driven development, demonstrated by outstanding results
Granted Patents 50+
Core Technology & Process Patent Portfolio
Over 50 national invention patents granted, covering core technology areas including cell engineering, protein expression, and antibody screening, forming a comprehensive intellectual property protection system.
SCI Publications 100+
High-Impact Academic Publications
Team members have published 100+ SCI papers in top international journals including Nature Biotechnology, Cell, and Blood, with total citations exceeding 3,000. Multiple research findings have been incorporated into industry guidelines.
National Research Projects 10+
National-Level Research Project Undertakings
Undertaken 10+ national-level research projects including the National Science and Technology Major Project for "Major New Drug Innovation" and National Natural Science Foundation, with research funding exceeding 200 million RMB.
Provincial Tech Center & Postdoctoral Station
High-Level Research Platform Development
Established a provincial-level enterprise technology center and postdoctoral research station, with 3,000㎡ of modern R&D laboratories equipped with internationally advanced instruments, providing solid hardware support for scientific innovation.
Join Our Scientific Journey
We look forward to partnering with global scientific talents to advance biopharmaceutical innovation
Join Us